Bibliography
- ILLES, P, ALEXANDRE RIBEIRO J: Molecular physiology of P2 receptors in the central nervous system. Eur. J. Pharmacol 483:5-17.
- NORTH RA: Molecular physiology of P2X receptors. (2002) Physiol. Rev. 82:1013-67.
- VIAL C, ROBERTS JA, EVANS RJ: Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol. Sci (2004) 25:487-493.
- BURNSTOCK G: Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin. Med. (2002) 2:45-53.
- JARVIS MF, BURGARD EC, MCGARAUGHTY S et al.: C. A-317491: a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. USA (2002) 99:17179-17184.
- MAGER PP, WEBER A ILLES P: Bridging the gap between structural bioinformatics and receptor research the membrane-embedded, ligand-gated, P2X glycoprotein receptor. Curr. Topics Med. Chem. (2004) 4:1657-1705.
- ROST B, SANDER C: Combining evolutionary information and neural networks to predict protein secondary structure. Proteins (1999) 19:55-72.
- ROST B: Review: protein secondary structure prediction continues to rise. J. Struct. Biol. (2002) 134:204-218.
- CHEN CP, ROST B: Long membrane helices and short loops predicted less accurately. Protein Sci. (2002) 11:2766-2773.
- CHEN CP, KERNYTSK A, ROST B: Transmembrane helix predictions revisited. Protein Sci. (2002) 11:2774-2291.
- CHEN CP, ROST B: State-of-the-art in membrane protein prediction. Appl. Bioinformatics (2002) 1:21-35.
- FARISELLI P, RICCOBELLI P, CASADIO R: Role of evolutionary information in predicting the disulfide-bonding state of cysteine in proteins. Proteins (1999) 36:340-346.
- DAYHOFF MO, BARKER WC , HUNT LT: Establishing homologies in protein sequences. Meth. Enzymol. (1983) 9:524-545.
- CORPET F: Multiple sequence alignment with hierarchical clustering. Nucl. Acids Res. (2002) 16:10881-10890.
- MAGER PP, WEBER A: Structural bioinformatics and QSAR analysis applied to the acetylcholinesterase and bispyridinium aldoximes. Drug Des. Discov. (2003) 18:127-150.
- FALQUET L, PAGNI M, BUCHER et al.: The PROSITE database, its status in 2002. Nucl. Acids Res. (2002):335-38.
- WIRKNER K, STANCHEV D, KÖLES L et al.: Regulation of human recombinant P2X3 receptors by ecto-protein kinase. J. Neurosci. (2005) 25:7734-7742.
- MAGER PP, WEBER A, ILLES P: Quantitative structure–activity relationship analysis of the cation permeability of the P2X2 channel. Med. Chem. (2005) 1:109-115.
- HU B, SENKLER C, YANG A, SOTO F, LLANG BT: P2X4 receptor is a glycosylated cardiac receptor mediating a positive inotropic response to ATP. J. Biol. Chem. (2002) 277:15752-15757.
- JONES CA, VIAL C, SELLERS LA, HUMPHREY PPA, EVANS RJ, CHESSELL IP: Functional regulation of P2X6 receptors by N-linked glycosylation: identification of a novel αβ-methylene ATP-sensitive phenotype. Mol. Pharmacol. (2004) 65:979-985.
- TORRES GE, EGAN TM, VOIGT MM: N-linked glycosylation is essential for the functional expression of the recombinant P2X2 receptor. Biochem. (1998) 37:14845-51.
- ZALIANI A, GROMO G, PINORI M, MASCAGNI P: Rational design of a new C-myristylamido peptide exerting potent and selective PKC inhibitory activity. Drug Des. Discov. (1996) 13:63-74.
- DUTTON JL, PORONNIK P, LI G: P2X(1) receptor membrane redistribution and down-regulation visualized by using receptor-coupled green fluorescent protein chimeras. Neuropharmacology (2000) 39:2054-2066.
- JENSIK P, COX T: ATP-induced internalization of amphibian epithelial P2X receptors is linked to channel opening. Pflügers Arch.Eur. J. Physiol. (2002) 444:795-800.
- ENNION S J, EVANS RJ: Agonist-stimulated internalisation of the ligand-gated ion channel P2X(1) in rat vas deferens. FEBS Lett. (2001) 489:154-158.
- LI GH, LEE EM, BLAIR D: The distribution of P2X receptor clusters on individual neurons in sympathetic ganglia and their redistribution on agonist activation. J. Biol. Chem. (2000) 275:29107-29112.
- BOBANOVIC LK, ROYLE SR, MURRELL-LAGNADO RD: P2X receptor trafficking in neurons is subunit specific. J. Neurosci.(2002) 22:4814-4824.
- HIKEN JF, STEINBERG TH: ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells.) Am. J. Physiol. Cell Physiol. (2004) 287:C403-C412.
- MIALET-PEREZ J, GREEN SA, MILLER WE, LIGGETT SB: A primate-dominant third glycosylation site of the beta2-adrenergic receptor routes receptors to degradation during agonist regulation. J. Biol. Chem. (2004) 279:38603-38607.
- VAGIN O, TURDIKULOVA S, SACHS G: The H,K-ATPase β subunit as a model to study the role of N-glycosylation in membrane trafficking and apical sorting. J. Biol. Chem. (2004) 279:39026-39034.
- MAGER PP, WEBER A, SANCHEZ L, WIRKNER K, ILLES P: The monomers of the P2X1 receptor model and KcsA protein share a similar structural fold. Protein Pept. Lett. (2006) 13:77-81.
- MAGER PP, WEBER A, WALTHER H, WIRKNER K, ILLES P: Perspectives in proteomics: structural folds of a predicted and an experimentally determined cation channel. Curr. Proteomics (2005) 2:319-324.
- BARALDI PG, DI VIRGILIO F, ROMAGNOLI R: Agonists and antagonists acting at P2X7 receptor. Curr. Topics Med. Chem. (2004) 4:1707-1717.
- HÜLSMANN M, NICKEL P, KASSAK M SCHMALZING G, LAMBRECHT G, MARKWARDT F: NF449: a novel picomolar potency antagonist at human P2X1 receptors. Eur. J. Pharmacol. (2003) 470:1-7.
- MCGARAUGHTY S, WISMER CT: Effects of A-317491: a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br. J. Pharmacol. (2003) 140:1381-1388.
- GARGETT CE, WILEY JS: The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br. J. Pharmacol (1997) 120:1483-1490.
- BARALDI PG, DEL CARMEN NUNEZ M, MORELLI A, FALZONI S, DI VIRGILIO F, ROMAGNOLI R: Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor. J. Med. Chem. (2003) 46:1318-1329.
- BAXTER A, BENT J, BOWERS K: Hit-to-lead studies: the discovery of potent adamantane amide P2X7 receptor antagonists. Bioorg. Med. Chem. Lett. (2003) 13:4047-4050.
- MERRIMAN GH, MA L, SHUM P: Synthesis and SAR of novel 4,5 diarylimidazolines as potent P2X7 receptor antagonists. Bioorg. Med. Chem. (2005) 15:435-438.
- SIMONS KT, BONNEAU R, RUCZINSKI I BAKER D: Ab initio protein structure prediction of CASP III targets using ROSETTA. Proteins (1999) 3:171-176.
- BONNEAU R, STRAUSS CEM, BAKER D: Improving the performance of rosetta using multiple sequence alignment information and global measures of hydrophobic core formation. Proteins (2001) 43:1-11.
- BYSTROFF C, SHAO Y: Fully automated ab initio protein structure prediction using I-SITES, HMMSTR and ROSETTA. Bioinformatics (2002) 18(Suppl. 1):S54-S61.